Zymeworks Inc (ZYME)

NASDAQ · Biotechnology

28.61
-0.10 (-0.35%)
Updated Oct 31, 7:49 PM ET
AI Rating
Buy
Overall Score
76
Trend
84
Momentum
83
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 17, 2025 260 sessions Oct 29, 2026

AI Analysis

Zymeworks Inc is trading at $28.61, down 0.35% on the session. The 50 day average sits at $27.26 and the 200 day at $25.20, which puts the stock in a uptrend. RSI is at 61.2, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $25.81 with resistance near $30.62, so that band frames the current range. Average daily movement is roughly $1.14, or about 4.0% of the share price, which is what any stop placement has to allow for. The overall health score of 76 out of 100 combines a trend score of 84, momentum of 83 and a risk score of 52.

Technical indicators

RSI (14)
61.2
strong
MACD
0.603
bullish crossover
SMA 20
26.63
SMA 50
27.26
SMA 200
25.20
uptrend
ATR (14)
1.14
avg daily range
Support
25.81
Resistance
30.62
Volume vs 20d
0.62x
below average
Volatility
44.8%
annualised
1 month
+8.38%
3 months
+30.86%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.